| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.11 | 0.6 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.1 | 0.6 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.11 | 0.6 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.025 | 0.6 |